Metraipolis › archive › dc_f5bf4cc0252c
Cafestol-derivatives as potential FXR agonists and CYP7A1 inhibitors and their impact on hypercholesterolemia: an in silico study — Europe PMC PMID:41634284
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41634284
- DOI
- 10.1038/s41598-[numero omesso]-6
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-06T04:05:50.567Z
- SHA-256 of the archived text
bd3edce0c33e3207b7d99fb8df80cfb6df3cc6e5674bd100897bc49cf335cb13- Stable URL of this page
https://metraipolis.com/documento/dc_f5bf4cc0252c
How to cite
Cafestol-derivatives as potential FXR agonists and CYP7A1 inhibitors and their impact on hypercholesterolemia: an in silico study — Europe PMC PMID:41634284 — Europe PMC (en), https://europepmc.org/article/MED/41634284 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_f5bf4cc0252c (Metraipolis archive dc_f5bf4cc0252c, sha256 bd3edce0c33e3207b7d99fb8df80cfb6df3cc6e5674bd100897bc49cf335cb13)
BibTeX
@misc{dcf5bf4cc0252c,
title = {Cafestol-derivatives as potential FXR agonists and CYP7A1 inhibitors and their impact on hypercholesterolemia: an in silico study — Europe PMC PMID:41634284},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41634284},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_f5bf4cc0252c; sha256 bd3edce0c33e3207b7d99fb8df80cfb6df3cc6e5674bd100897bc49cf335cb13},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41634284. Agents can read the archived copy with the MCP tool read_document.